Author

Katherine D. Kundel

Observed institutions: University of Minnesota, University of Minnesota, Duluth

OpenAlex ID: A5088041360

Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors

2009 · Teresa A. Rose-Hellekant, Andrew J. Skildum, et al. · Cancer Prevention Research · 6

Supplementary Figure 1 from Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors

2023 · Teresa A. Rose-Hellekant, Andrew J. Skildum, et al.

Supplementary Figure 1 from Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors

2023 · Teresa A. Rose-Hellekant, Andrew J. Skildum, et al.

Data from Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors

2023 · Teresa A. Rose-Hellekant, Andrew J. Skildum, et al.

Data from Short-term Prophylactic Tamoxifen Reduces the Incidence of Antiestrogen-Resistant/Estrogen Receptor–Positive/Progesterone Receptor–Negative Mammary Tumors

2023 · Teresa A. Rose-Hellekant, Andrew J. Skildum, et al.

Works count: 5

Citation count: 6

H-index: 1

I10-index: